Page Health & Life Sciences Novel treatments, medical devices, diagnostics, and research tools spanning a range of therapeutic areas.
News Digital Health, Therapeutics Startups Selected for George Shultz Innovation Fund Finals The Polsky Center for Entrepreneurship and Innovation at the University of Chicago has announced the companies selected for the 2022 fall cohort of the George Shultz Innovation Fund. Managed by the...
News Life Sciences, Tech Startups Advance to Fall 2023 George Shultz Innovation Fund Finals Researchers have developed a proprietary machine learning approach, multi-tissue human organoid model, and a targeted drug delivery method – and will be seeking investment at the fall 2023 George Shultz...
News Compass Demo Day to Feature 5 Investor-Ready Deep Tech Startups Polsky Science Ventures and the Compass deep tech accelerator team at the University of Chicago are hosting a “demo day” to highlight innovative research and technologies seeking growth opportunities. Representing...
News 50 Companies to Pitch to Investors at DeepTechU The DeepTechU venture conference will showcase 50 startups during the three-day virtual event May 3 to 5, giving investors an early look at cutting-edge deep tech innovation coming out of universities,...
News Midwest Biotech Startup Showcase Spotlights 30+ Breakthrough Innovations from Leading Research Institutions Bringing breakthrough science to the forefront of innovation, the Midwest Biotech Startup Showcase will highlight more than 30 emerging life sciences and biotech ventures from leading research institutions across the...
News Using Nanotechnology to Deliver ‘Potentially Transformative’ Peptide-Based Therapeutics A physician-scientist, James Labelle is developing therapies that modify the function of the immune system – by examining why, on a molecular level, some pediatric cancers are resistant to treatment....
News Alnair Therapeutics Awarded $175,000 From George Shultz Innovation Fund The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected oncology startup Alnair Therapeutics as a Fall 2022 cohort award winner. The company,...
News George Shultz Innovation Fund Invest in Anapneo Therapeutics at Its Spring Finals Finalists presented their proposals to the Innovation Fund advisory committee at the finals on June 5.
News Riptide Therapeutics Awarded $175,000 From George Shultz Innovation Fund The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected Riptide Therapeutics, a biopharmaceutical startup led by University of Chicago and Northwestern University...
